Development of the RXR agonist IRX4204 to treat multiple sclerosis and other immu

Ended Project Grant Awarded Last action

Award ID
R43AI112512
Recipient
Awarding agency
Obligated
$225,000

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Place of performance
Santa Ana, CA 92707, USA

Award details come from USAspending.gov.

Quick answers

Who received award R43AI112512?

R43AI112512 was awarded to IO Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on June 11, 2014.

How much is award R43AI112512 worth?

$225,000 has been obligated on R43AI112512.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award